Skip to main content

CORRECTION

Transpl Int, 09 October 2023

Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry

Alessandra Francica
Alessandra Francica1*Antonio Loforte,Antonio Loforte2,3Matteo AttisaniMatteo Attisani3Massimo MaianiMassimo Maiani4Attilio IacovoniAttilio Iacovoni5Teodora NisiTeodora Nisi6Marina ComissoMarina Comisso7Amedeo TerziAmedeo Terzi5Michele De BonisMichele De Bonis6Igor VendraminIgor Vendramin4Massimo BoffiniMassimo Boffini3Francesco MusumeciFrancesco Musumeci7Giovanni Battista LucianiGiovanni Battista Luciani1Mauro RinaldiMauro Rinaldi3Davide PaciniDavide Pacini2Francesco OnoratiFrancesco Onorati1
  • 1Division of Cardiac Surgery, University Hospital of Verona, Verona, Italy
  • 2Division of Cardiac Surgery, S. Orsola University Hospital, IRCCS Bologna, Bologna, Italy
  • 3City of Health and Science Hospital, Cardiac Surgery University Unit, University of Turin, Turin, Italy
  • 4Division of Cardiac Surgery, Ospedale S. Maria della Misericordia, Udine, Italy
  • 5Division of Cardiac Surgery, Papa Giovanni XXII Hospital of Bergamo, Bergamo, Italy
  • 6Division of Cardiac Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy
  • 7Division of Cardiac Surgery, San Camillo Forlanini Hospital, Rome, Italy

A Corrigendum on
Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry

by Francica A, Loforte A, Attisani M, Maiani M, Iacovoni A, Nisi T, Comisso M, Terzi A, De Bonis M, Vendramin I, Boffini M, Musumeci F, Luciani GB, Rinaldi M, Pacini D and Onorati F (2023). Transpl Int. 36:11675. doi: 10.3389/ti.2023.11675

In the original article, there was a mistake in the Graphical Abstract as published. The propensity-score matching survival was incorrectly given as “64.1% vs. 81.3% (p .02)”. The correct values are “64.1% for HM3 vs. 41.7% in HVAD (p 0.02)”. The Kaplan-Meier curve is correct, it was just a transcription error.

GRAPHICAL ABSTRACT
www.frontiersin.org

GRAPHICAL ABSTRACT

The corrected Graphical Abstract appears below.

The same mistake was present in the text body. A correction has been made to the Abstract and to the Results section:

Abstract: “The propensity-score matching analysis (130 pairs of HVAD vs. HM3) confirmed a significantly lower 5 years survival (41.7% vs. 64.1%; p 0.02)…”

Results, Propensity Matched Population: “HVAD patients confirmed a significantly lower 5 years survival (64.1% vs. 41.7%; p 0.02) (Figure 2B)…”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: continuous-flow LVAD, HeartMate3, HeartWare, full-magnetic levitation pump, hybrid levitation system pump

Citation: Francica A, Loforte A, Attisani M, Maiani M, Iacovoni A, Nisi T, Comisso M, Terzi A, De Bonis M, Vendramin I, Boffini M, Musumeci F, Luciani GB, Rinaldi M, Pacini D and Onorati F (2023) Corrigendum: Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry. Transpl Int 36:12088. doi: 10.3389/ti.2023.12088

Received: 21 September 2023; Accepted: 25 September 2023;
Published: 09 October 2023.

Copyright © 2023 Francica, Loforte, Attisani, Maiani, Iacovoni, Nisi, Comisso, Terzi, De Bonis, Vendramin, Boffini, Musumeci, Luciani, Rinaldi, Pacini and Onorati. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alessandra Francica, YWxlc3NhbmRyYWZyYW5jaWNhQHlhaG9vLml0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.